Skip to content
Catalyst
Search

Papers/PMID:31096444

The clinical outcomes of selenium supplementation on critically ill patients: A meta-analysis of randomized controlled trials.

Medicine2019The record

1 finding · 1 compound · 1 endpoint

What it reported

How to read these marks

What moved

1 finding

  • selenium atom — decreases all-cause mortality

    Evidence strength: moderate.Findingreplicated ×7
    “The result indicated that selenium supplement could reduce the overall mortality compared with placebo or no intervention in critically ill patients (RR 0.86, 95% CI 0.78–0.95, P =.002) using a fixed effects model (I2 = 24%, P =.17).”
    Quoted verbatim from The clinical outcomes of selenium supplementation on critically ill patients: A meta-analysis of randomized controlled trials..
    Study
    meta-analysis
    Population
    Critically ill patients (SIRS, sepsis, septic shock, multiple organ failure) in randomised trials of intravenous selenium; total mortality regardless of follow-up period

    Effect 0.86 risk ratio, 95% CI 0.78 to 0.95

    The clinical outcomes of selenium supplementation on critically ill patients: A meta-analysis of randomized controlled trials.2019PMID:3109644410.1097/MD.0000000000015473Permalink